Explaining how and why the US Food and Drug Administration has championed pharmacogenomics. (2015)
Attributed to:
State strategies of governance in global biomedical innovation: the impact of China and India
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Publication URI: http://www.sciencedirect.com/science/article/pii/S0277953615000313
Type: Journal Article/Review
Volume: 131
Parent Publication: Social Science & Medicine